Sfoglia per Corso ONCOLOGIA MEDICA Specializzazione (D.I.68/2015)
Modern Therapeutic Strategies in Anaplastic Thyroid Carcinoma: Real-World Outcomes of Targeted Therapy and Immunotherapy
2023/2024 MICHELETTO, ILARIA
Oxaliplatin- and temozolomide-based therapy in metastatic GEP-NETs: a monocentric comparison.
2023/2024 CERANTOLA, RICCARDO
Prognostic and predictive impact of HER2 expression in metastatic urothelial carcinoma: results from the single-center BladdHER study.
2023/2024 ERBETTA, ELISA
Radiomic approach to support Multidisciplinary Tumor Board decision-making in Locally Advanced Non-Small Cell Lung Cancer
2023/2024 DE NUZZO, MATTIA
Real-World outcomes of Darolutamide + docetaxel + androgen deprivation therapy combination in patients with metastatIc castration sensitive prostate cancer within the Italian multicenter observational study (ECHOS trial)
2022/2023 CAVASIN, NICOLÒ
Role of sidedness in pMMR/MSS BRAF mutated metastatic colorectal cancer: descriptive and prognostic analyses from a large real-world clinical cohort
2023/2024 PERISSINOTTO, ELEONORA
SLFN11 as a Biomarker in Lung Neuroendocrine Tumors: Analysis of Carcinoids, LCNEC, and SCLC
2023/2024 SCATTOLIN, DANIELA
The Role of Liquid Biopsy in Risk Stratification for Patients with EGFR-Mutant Advanced NSCLC Treated with Osimertinib
2023/2024 BAO, LOC CARLO
Un modello integrato per predire il rischio di eventi avversi immuno-correlati nel carcinoma polmonare non a piccole cellule in stadio avanzato: i risultati di uno studio nella pratica clinica.
2022/2023 MULARGIU, CRISTIANA
Valutazione della risposta patologica completa (pCR) come endpoint surrogato per la sopravvivenza nel carcinoma mammario triplo negativo (TNBC) precoce trattato con chemio‑immunoterapia neoadiuvante: una meta‑analisi di studi randomizzati controllati.
2023/2024 ZURLO, CHRISTIAN
| Tipologia | Anno | Titolo | Titolo inglese | Autore | File |
|---|---|---|---|---|---|
| Scuole di Specializzazione | 2023 | Modern Therapeutic Strategies in Anaplastic Thyroid Carcinoma: Real-World Outcomes of Targeted Therapy and Immunotherapy | Modern Therapeutic Strategies in Anaplastic Thyroid Carcinoma: Real-World Outcomes of Targeted Therapy and Immunotherapy | MICHELETTO, ILARIA | |
| Scuole di Specializzazione | 2023 | Oxaliplatin- and temozolomide-based therapy in metastatic GEP-NETs: a monocentric comparison. | Oxaliplatin- and temozolomide-based therapy in metastatic GEP-NETs: a monocentric comparison. | CERANTOLA, RICCARDO | |
| Scuole di Specializzazione | 2023 | Prognostic and predictive impact of HER2 expression in metastatic urothelial carcinoma: results from the single-center BladdHER study. | Prognostic and predictive impact of HER2 expression in metastatic urothelial carcinoma: results from the single-center BladdHER study. | ERBETTA, ELISA | |
| Scuole di Specializzazione | 2023 | Radiomic approach to support Multidisciplinary Tumor Board decision-making in Locally Advanced Non-Small Cell Lung Cancer | Radiomic approach to support Multidisciplinary Tumor Board decision-making in Locally Advanced Non-Small Cell Lung Cancer | DE NUZZO, MATTIA | |
| Scuole di Specializzazione | 2022 | Real-World outcomes of Darolutamide + docetaxel + androgen deprivation therapy combination in patients with metastatIc castration sensitive prostate cancer within the Italian multicenter observational study (ECHOS trial) | Real-World outcomes of Darolutamide + docetaxel + androgen deprivation therapy combination in patients with metastatIc castration sensitive prostate cancer within the Italian multicenter observational study (ECHOS trial) | CAVASIN, NICOLÒ | |
| Scuole di Specializzazione | 2023 | Role of sidedness in pMMR/MSS BRAF mutated metastatic colorectal cancer: descriptive and prognostic analyses from a large real-world clinical cohort | Role of sidedness in pMMR/MSS BRAF mutated metastatic colorectal cancer: descriptive and prognostic analyses from a large real-world clinical cohort | PERISSINOTTO, ELEONORA | |
| Scuole di Specializzazione | 2023 | SLFN11 as a Biomarker in Lung Neuroendocrine Tumors: Analysis of Carcinoids, LCNEC, and SCLC | SLFN11 as a Biomarker in Lung Neuroendocrine Tumors: Analysis of Carcinoids, LCNEC, and SCLC | SCATTOLIN, DANIELA | |
| Scuole di Specializzazione | 2023 | The Role of Liquid Biopsy in Risk Stratification for Patients with EGFR-Mutant Advanced NSCLC Treated with Osimertinib | The Role of Liquid Biopsy in Risk Stratification for Patients with EGFR-Mutant Advanced NSCLC Treated with Osimertinib | BAO, LOC CARLO | |
| Scuole di Specializzazione | 2022 | Un modello integrato per predire il rischio di eventi avversi immuno-correlati nel carcinoma polmonare non a piccole cellule in stadio avanzato: i risultati di uno studio nella pratica clinica. | An integrated model to predict the risk for immune-related adverse events in advanced Non-small cell lung cancer: the results from a large real-world study. | MULARGIU, CRISTIANA | |
| Scuole di Specializzazione | 2023 | Valutazione della risposta patologica completa (pCR) come endpoint surrogato per la sopravvivenza nel carcinoma mammario triplo negativo (TNBC) precoce trattato con chemio‑immunoterapia neoadiuvante: una meta‑analisi di studi randomizzati controllati. | Evaluating Pathologic Complete Response (pCR) as a Surrogate Endpoint for Survival in Early Triple Negative Breast Cancer (TNBC) Treated with Neoadjuvant Chemo-Immunotherapy: A Meta Analysis of Randomized Controlled Studies. | ZURLO, CHRISTIAN |
Legenda icone
- file ad accesso aperto
- file ad accesso riservato
- file sotto embargo
- nessun file disponibile